Age-related macular degeneration (AMD) is a disease originating in the retina, which may worsen over time, according to WebMD. It’s said to be the leading cause of severe, permanent vision loss in people older than 60. When the macula — the small central portion of the retina — wears down, the light-sensing nerve tissue at the […]

Grant is the Chief Business Officer with Bolt BioTherapeutics. Bolt Bio recently went public in February this year and announced a partnership with Genmab. Grant talks business development strategy and helping to navigate Bolt through their recent milestones. Bolt Bio focuses on the development of ISACs – immune-stimulating antibody conjugates – which are anti-cancer drugs […]

James Mackay, President & CEO, Aristea Therapeutics, serves as an independent board member to two other San Diego-based biopharma companies: Arthrosi Therapeutics and MatriSys Bioscience, and Peabody, MA-based Privo Technologies. What exactly is an independent board member? Mackay keeps it simple: A board member with no (or limited) vested financial interest in the company they’ve been asked to guide.